Paroxetine and rivastigmine mitigates adjuvant-induced rheumatoid arthritis in rats: Impact on oxidative stress, apoptosis and RANKL/OPG signals
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 212, 109-118
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated ratsActa Pharmacologica Sinica, 2011
- Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll‐like receptorsArthritis & Rheumatism, 2010
- Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathwayBrain, Behavior, and Immunity, 2009
- Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expressionEuropean Neuropsychopharmacology, 2007
- Biology of RANK, RANKL, and osteoprotegerinArthritis Research & Therapy, 2007
- Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitorsNeuropharmacology, 2006
- Female Preponderance for Development of Arthritis in Rats is Influenced by both Sex Chromosomes and Sex SteroidsScandinavian Journal of Immunology, 1995
- High sensitivity to androgen as a contributing factor in sex differences in the immune responseArthritis & Rheumatism, 1979
- Approach to the study of the role of sex hormones in autoimmunityArthritis & Rheumatism, 1979
- Studies of the effects of sex hormones on autosomal and x‐linked genetic control of induced and spontaneous antibody productionArthritis & Rheumatism, 1979